Sangamo BioSciences Announces Presentation At The 35th Annual J.P. Morgan Healthcare Conference
Get Alerts SGMO Hot Sheet
Join SI Premium – FREE
RICHMOND, Calif., Jan. 4, 2017 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Sandy Macrae, M.B., Ch.B., Ph.D, Sangamo's chief executive officer, will participate in the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11th at 4:30 p.m. Pacific Time in San Francisco, California.
To access the live webcast, please visit the Investor and Media section of the Sangamo website, www.sangamo.com. The presentation will be archived on the Sangamo website for two weeks after the event.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sangamo-biosciences-announces-presentation-at-the-35th-annual-jp-morgan-healthcare-conference-300385667.html
SOURCE Sangamo BioSciences, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Increasing unusual option volume: SGMO MGA MTTR IPG HUYA WSC
- Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology
- Perceptyx Launches Activate, HR’s Missing Link Between Employee Insight and Impact
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!